Ubs Global Asset Management Americas »

BioCryst Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 395k 7.59
2025-06-30 $6.2M 692k 8.96
2025-03-31 $3.4M 449k 7.50
2024-12-31 $3.0M 401k 7.52
2024-09-30 $3.0M 390k 7.60
2024-06-30 $2.7M 433k 6.18
2024-03-31 $1.3M 247k 5.08
2023-12-31 $1.5M 247k 5.99
2023-09-30 $1.7M 237k 7.08
2023-06-30 $2.0M 237k 8.34
2023-03-31 $2.0M 237k 8.34
2022-12-31 $2.3M 204k 11.48
2022-09-30 $2.6M 204k 12.60
2022-06-30 $2.1M 201k 10.58
2022-03-31 $3.8M 231k 16.26
2021-12-31 $2.8M 204k 13.85
2021-09-30 $2.5M 175k 14.37
2021-06-30 $3.7M 234k 15.81
2021-03-31 $2.4M 233k 10.17
2020-12-31 $4.0M 1.2M 3.44
2020-09-30 $4.0M 1.2M 3.44
2020-06-30 $5.5M 1.2M 4.77
2020-03-31 $233k 116k 2.00
2019-12-31 $441k 128k 3.45
2019-09-30 $211k 74k 2.86
2019-06-30 $250k 66k 3.79
2019-03-31 $498k 61k 8.14
2018-12-31 $388k 48k 8.07
2018-09-30 $367k 48k 7.63
2018-06-30 $275k 48k 5.73
2018-03-31 $287k 60k 4.77
2017-12-31 $207k 42k 4.91
2017-09-30 $221k 42k 5.24
2017-06-30 $221k 40k 5.56
2017-03-31 $392k 47k 8.40
2016-09-30 $120k 27k 4.43
2016-06-30 $77k 27k 2.84
2016-03-31 $77k 27k 2.84
2015-12-31 $282k 27k 10.33
2015-09-30 $339k 30k 11.41
2015-06-30 $426k 29k 14.95
2015-03-31 $236k 26k 9.04
2014-12-31 $300k 25k 12.15
2014-09-30 $211k 22k 9.77
2014-06-30 $261k 21k 12.73
2014-03-31 $217k 21k 10.59
2013-12-31 $156k 21k 7.61